response to epirubicin
|
phenotype |
|
Cell Function
|
1
|
1
|
0.100 |
None |
1.000 |
1 |
1
|
2013 |
2013 |
Ventilatory defect
|
disease |
Respiratory Tract Diseases
|
Disease or Syndrome
|
4
|
1
|
0.010 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Retinal Perforations
|
group |
Eye Diseases
|
Disease or Syndrome
|
5
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
ASA intolerant asthma
|
disease |
Respiratory Tract Diseases; Immune System Diseases
|
Disease or Syndrome
|
9
|
|
0.010 |
None |
< 0.001 |
1 |
|
2005 |
2005 |
Thrombotic stroke
|
disease |
Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
11
|
1
|
0.020 |
None |
1.000 |
2 |
|
2007 |
2009 |
Cerebral Infarction, Left Hemisphere
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
11
|
|
0.300 |
None |
|
0 |
|
|
|
Cerebral Infarction, Right Hemisphere
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
11
|
|
0.300 |
None |
|
0 |
|
|
|
Anterior Choroidal Artery Infarction
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
11
|
|
0.300 |
None |
|
0 |
|
|
|
Posterior Choroidal Artery Infarction
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
11
|
|
0.300 |
None |
|
0 |
|
|
|
Subcortical Infarction
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
13
|
|
0.300 |
None |
|
0 |
|
|
|
Encephalopathy, Toxic
|
disease |
Nervous System Diseases; Chemically-Induced Disorders
|
Injury or Poisoning
|
29
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Toxic Encephalitis
|
disease |
Nervous System Diseases; Chemically-Induced Disorders
|
Injury or Poisoning
|
29
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Xanthoma
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
29
|
4
|
0.010 |
None |
1.000 |
1 |
1
|
2009 |
2009 |
Neurotoxicity Syndromes
|
group |
Nervous System Diseases; Chemically-Induced Disorders
|
Injury or Poisoning
|
34
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Macular Holes
|
disease |
Eye Diseases
|
Disease or Syndrome
|
42
|
|
0.050 |
None |
1.000 |
5 |
|
2017 |
2018 |
Myocardial infarction, stroke
|
disease |
|
Disease or Syndrome
|
46
|
3
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Hyperoxia
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
50
|
|
0.200 |
None |
1.000 |
1 |
|
2002 |
2002 |
Atherogenesis
|
phenotype |
Cardiovascular Diseases
|
Pathologic Function
|
59
|
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Liver Dysfunction
|
phenotype |
Digestive System Diseases
|
Finding
|
73
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Chronic idiopathic urticaria
|
disease |
Skin and Connective Tissue Diseases; Immune System Diseases
|
Disease or Syndrome
|
89
|
9
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Retinal Detachment
|
disease |
Eye Diseases
|
Disease or Syndrome
|
148
|
10
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2018 |
Pulmonary Hypertension
|
phenotype |
Respiratory Tract Diseases
|
Pathologic Function
|
156
|
|
0.200 |
None |
1.000 |
1 |
|
1996 |
1996 |
Hyperlipoproteinemia Type IIa
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
201
|
661
|
0.020 |
None |
1.000 |
2 |
|
2009 |
2009 |
Hypercholesterolemia, Familial
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
203
|
1423
|
0.020 |
None |
1.000 |
2 |
|
2009 |
2009 |
Mammary Neoplasms, Experimental
|
phenotype |
Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
218
|
|
0.200 |
None |
1.000 |
1 |
|
2008 |
2008 |